Table 2.
Case | Presentation | Maximum tumour diameter (mm) | Cavernous sinus or sphenoid sinus invasion | Status after surgery | Follow-up duration (months) | Treatment with SRL | Recurrence or progression |
---|---|---|---|---|---|---|---|
1 | Acromegaly | 19 | No | Cure | 48 | – | No |
2 | Acromegaly, amenorrhoea | 28 | Yes | Residual macrotumour | – | – | – |
3 | Acromegaly | 12 | No | Biochemical persistence | 129 | Yes | No |
4 | Acromegaly, amenorrhoea | 38 | No | Residual macrotumour | 132 | Yes | No |
5 | Visual field deficit | 32 | Yes | Residual macrotumour | 34 | No | No |
6 | Acromegaly | 15 | No | Cure | 50 | – | No |
7 | Acromegaly | 24 | No | Cure | 59 | – | No |
8 | Acromegaly | 12 | No | Cure | 36 | – | No |
9 | Acromegaly | 8 | No | Cure | 12 | – | No |